CELONOVA

Pioneers in Cardiovascular Innovation

Our Company

CeloNova BioSciences is an innovative global medical device leader. CeloNova is led by the industry’s most experienced executive leaders and board members.

Leveraging its novel Polyzene-F core technology, CeloNova is transforming the treatment of cardiovascular disease and promoting positive outcomes in patients around the world.

The proprietary COBRA PzF NanoCoated Coronary Stent System is the latest generation stent featuring the nano-thin Polyzene-F nanocoated surface modification.

In 2015, CeloNova’s interventional radiology product lines were acquired by Boston Scientific. Click here to read the press release.

Board of Directors

Mark C. Bates, MD, DSC, FACC, FSCAI

Director

Dr. Bates is Director of the CAMC Cardiovascular Medicine Fellowship and Senior Scientist for Cardiovascular Research at the CAMC Research Institute. He is the Founder and Co-Director of the CAMC Vascular Center of Excellence and is Clinical Professor of Medicine and Surgery at West Virginia University School of Medicine in Charleston, WV. He is considered a thought leader in cardiovascular medicine having authored over 100 manuscripts/book chapters. Dr. Bates has performed 1000s of cardiovascular procedures and has been the site principle investigator (PI) and national PI for several US and International Clinical Trials.

Dr. Bates is also a successful entrepreneur and inventor. His passion in the field of endovascular surgery has resulted in key innovative advances with over 50 US issued / pending patents in the arenas of embolic protection, nanotechnology, stent design, cell therapy, catheter design, guide-wire design, drug eluting balloons and local drug delivery. He has been on the advisory boards of Guidant, Boston Scientific and Medtronic and has served on the Johnson & Johnson Opinion Leaders Council. He is also currently Chairman of the Board for Nexeon MedSystems, Nevada Corp.

Mark graduated from West Virginia University School of Medicine and completed his Internal Medicine residency at WVU followed by a cardiovascular fellowship at the University of Kentucky. He then was retained as a Clinical Scholar in Interventional Cardiology and Research at UK followed by a Fellowship in Vascular Medicine and Complex Vascular Intervention / Research at the Dorros-Feuer CV Research Foundation / University of Wisconsin. In 2014 Dr. Bates was honored with a Doctor of Science Degree from University of Charleston and Received the American Heart Association Heart of Gold Award in 2015.

Harry Jacobson, MD

Director

Dr. Jacobson is former Vice Chancellor for Health Affairs at Vanderbilt University and Chief Executive Officer of Vanderbilt University Medical Center (VUMC). During his more than 11 years of tenure, VUMC revenues grew from $750 million to $2.5 billion, while delivering superior care at substantially lower costs than those in similar hospitals. Its federally-funded NIH research program moved from 24th to the top 10 in the country, and over $1 billion of newly-constructed research and patient care facilities were opened during his tenure.

Dr. Jacobson has been a successful investor and entrepreneur, as well, having founded or co-founded more than ten companies, including Contact Software, Renal Care Group and Ambulatory Services of America. He has been both a formal and informal advisor to several venture and private equity funds. He formerly served on the Board of Directors of Kinetic Concepts, Inc. and Merck. Dr. Jacobson currently serves as Chairman of the Board of MedCare Investment Funds, a privately-held healthcare investment group.

Harry received his Doctor of Medicine degree from the University of Illinois in 1972 and completed his medical residency at Johns Hopkins Hospital and specialty training in nephrology at the University of Texas Health Science Center in Dallas.

Thomas (Tim) Lyles, JD

Director

 

Mr. Lyles is President of Mission City Management, Inc. and MedCare Investment Funds. Mr. Lyles has managed an investment portfolio for over twenty years, including both public and large private companies. He also serves on numerous for-profit and non-profit Boards of Directors. Mr. Lyles’ primary responsibility is President of a private holding company, which oversees both strategic and operational issues for various fund portfolios. Mr. Lyles has helped organize each fund in the MedCare Investment Funds group and has served as President of each fund since 1991. As a founding partner, Mr. Lyles was an active member of management in founding Renal Care Group along with Dr. Jacobson and the late Sam Brooks. Mr. Lyles, through his role as President of MedCare Investment Funds, has founded and established numerous health care companies.

From 1984 to 1989, Mr. Lyles was an Attorney with the law firm of Haynes and Boone in Dallas, Texas. During 1986 and 1987, he taught Real Estate Financing at Southern Methodist University in Dallas. From 1983 to 1984, he was appointed a Briefing Attorney for the Chief Justice of the Supreme Court of Texas.

Tim received his Juris Doctorate Cum Laude from SMU School of Law. Prior to attending law school, he was employed by KPMG Peat Marwick. Mr. Lyles earned an accounting degree from Texas A & M University, where he graduated Summa Cum Laude. In addition, Mr. Lyles is a Certified Public Accountant and has written material for the Texas State Bar and has been a speaker for the State Bar of Texas and the Dallas Bar.

Goetz M. Richter, MD, PHD

Director

Dr. Richter is the Director of the Clinics for Diagnostic and Interventional Radiology of the Klinikum Stuttgart. Dr. Richter is a co-founder of IMED, which became CeloNova BioSciences, Inc. in October of 2005. He is widely recognized as one of the pioneers in the development of stent technology, and was one of the first physicians to place a stent in a human being. He was one of the Principal Investigators and played a key role in the development and the clinical trials of the Palmaz Stent. A noted author and lecturer, Dr. Richter is regarded as one of the leading interventional radiologists in the world.

Goetz completed his undergraduate work at the University of Stuttgart-Hohenheim and earned a Doctor of Medicine degree from University Freiberg. He is currently serving as the President of the German Society of Interventional Radiology.

Gerhard Bette

Director

Mr. Bette is a Director Emeritus of McKinsey & Company, Inc., the pre-eminent global consulting firm. He retired from McKinsey’s Chicago office at the end of October 2010 after more than 28 years. At McKinsey, Mr. Bette held a range of internal leadership roles and is one of the co-founders of McKinsey’s global telecommunication practice. He also served as the leader of its North American telecommunication practice for many years. His practice focused on working with senior teams of technology-based companies in healthcare, IT and telecommunications industries. Mr. Bette has also worked with several leading Private Equity firms on due diligence efforts and portfolio company management issues.

Since his retirement, he has continued to be active as an advisor to several of his former clients and serves on two private equity held portfolio company boards. He is also an Adjunct Lecturer at the Department of Management, Organization and Strategy at the Kellogg School of Management at Northwestern University.

Mr. Bette holds an MBA from the Harvard Business School, a Doctorate in Mathematics from the University of Duisburg, Germany. He graduated from the University of Dortmund, Germany with a degree in Mathematics and studied at the Universite Pierre et Marie Curie, Paris with post graduate scholarships from the French and German governments.

Nurture your Unique Potential

At CeloNova BioSciences, you’ll have the opportunity to further your potential by joining a team of cutting edge cardiovascular innovators and leaders dedicated to transforming the treatment of coronary artery disease. Here you’ll discover challenges that develop you professionally, allowing you to explore a customer-centric culture with a hunger for innovation and improvement.

For a complete list of available career opportunities please contact CeloNova Human Resources at smaldonado@celonova.com.

I acknowledge that I am entering CeloNova’s international website.

Yes ​No